# Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer

> **NCT00002487** · PHASE2 · UNKNOWN · sponsor: **Ottawa Regional Cancer Centre**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** dipyridamole
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT00002487
- **Lead sponsor:** Ottawa Regional Cancer Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1991-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002487, "Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*